Interleukin-1o and Psoriasis

QUAN Cheng,YANG Sen,ZHANG Xue-Jun
DOI: https://doi.org/10.3760/cma.j.issn.1673-4173.2006.06.016
2006-01-01
International Journal of Dermatology and Venereology
Abstract:Psoriasis is a common chronic inflammatory skin disease, and immunoregulation abnormality is one of the important factors involved in its pathogenesis. Interleukin-10 is a pluripotent cytokine with major impacts on several immune responses, including inhibiting keratinocyte proliferation and differentiation, promoting type 1/ type 2 cytokine balance shift, decreasing cutaneous T cell infiltration. The antipsoriatic activity of IL-10 has been demonstrated in clinical trials. And it could be a promising candidate for the treatment of psoriasis.
What problem does this paper attempt to address?